JACC in a Flash | Persistent Excess CV Mortality in Black Americans; TAVR at 10 Years; More
Featured topics and Editors' Picks from all of ACC's JACC Journals.
Despite modest improvements from 2023 to 2024, Black Americans continue to experience significantly higher rates of cardiovascular mortality, according to the third annual JACC progress report examining disparities compared with White Americans.
Treatment of hypertension and hyperlipidemia remains low among U.S. adults with cardiovascular-kidney-metabolic (CKM) syndrome, with less than half achieving blood pressure (BP) or glycemic control, according to research published in JACC.
A novel risk score may help clinicians identify patients with cancer-associated venous thromboembolism (VTE) who are at higher risk for major bleeding while receiving direct oral anticoagulants (DOAC), according to research by Tomoyuki Nagai, MD, et al., published in JACC: CardioOncology.
Combined assessment of LDL-C, Lp(a) and hsCRP identified individuals from varied ethnic backgrounds at higher long-term risk of atherosclerotic cardiovascular disease (ASCVD), according to a HELIUS cohort analysis published in JACC.
Ten-year results from PARTNER 2A and a propensity-matched PARTNER 2 SAPIEN 3 (P2S3i) analysis, published in a JACC focus issue on valvular heart disease, provide new long-term context for TAVR vs. surgery in intermediate-risk patients with severe symptomatic aortic stenosis.
Clinical Topics: Cardiac Surgery, Cardiovascular Care Team, Dyslipidemia, Invasive Cardiovascular Angiography and Intervention, Prevention, Pulmonary Hypertension and Venous Thromboembolism, Valvular Heart Disease, Aortic Surgery, Cardiac Surgery and VHD, Advanced Lipid Testing, Lipid Metabolism, Nonstatins, Interventions and Structural Heart Disease, Interventions and Vascular Medicine, Hypertension
Keywords: Cardiology Magazine, ACC Publications, CM-Sep-2026, Social Determinants of Health, Health Equity, Glycemic Control, Health Promotion, Blood Pressure, Hyperlipidemias, Heart Disease Risk Factors, Cardio-oncology, Diabetes Mellitus, Kidney, Cholesterol, Hypertension, Venous Thromboembolism, Venous Thrombosis, Risk Assessment, Thrombosis, Lipoprotein(a), Cholesterol, LDL, C-Reactive Protein, Cardiovascular Diseases, Transcatheter Aortic Valve Replacement, Heart Valve Diseases, Aortic Valve Stenosis, Aortic Valve, Heart Valve Prosthesis, Prostheses and Implants, Biomarkers
